glp-1/gip/gcg receptor agonist GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica The Influence of Glucagon-like Peptide-1

Subcutaneous (SubQ) injection is the superior route for AHK-Cu based on current pharmacokinetic evidence

Never touch needle tips to any non-sterile surface

However, WADA's S2 category ("Peptide Hormones, Growth Factors, Related Substances and Mimetics") prohibits growth-factor peptides that are not approved for therapeutic use

A practical tutorial on conducting meta-analysis in R

Its sometimes discussed in biohacking circles for: Fat reduction support Muscle retention Recovery enhancement A human pharmacokinetic/pharmacodynamic clinical trial investigated ipamorelin in healthy male volunteers using dose-escalation infusions